FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377270003: Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3501624018 Carbidopa 25 mg and levodopa 250 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3677298019 Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4721821000005116 carbidopa25 mg + levodopa 250 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    carbidopa25 mg + levodopa 250 mg tablet Is a Product containing levodopa (medicinal product) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Is a Product containing carbidopa (medicinal product) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levodopa (substance) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbidopa false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Is a Product containing carbidopa and levodopa (medicinal product) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Is a Product containing carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet Has presentation strength denominator value en false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbidopa false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Carbidopa false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet Has presentation strength numerator value 25 false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Levodopa (substance) false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Levodopa (substance) false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet Has presentation strength numerator value 250 false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Levodopa (substance) false Inferred relationship Some 2
    carbidopa25 mg + levodopa 250 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Carbidopa false Inferred relationship Some 1
    carbidopa25 mg + levodopa 250 mg tablet Count of base of active ingredient to false Inferred relationship Some
    carbidopa25 mg + levodopa 250 mg tablet Is a Product containing only carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-careldopa 25mg/250mg tablet Is a False carbidopa25 mg + levodopa 250 mg tablet Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    US English

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start